Skip to main content
Margaret M. Newhams on Muck Rack

Margaret M. Newhams

As seen in: Center for Disease Control and Prevention, Wiley Online Library, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, The New England Journal of Medicine, EClinicalMedicine, The Journal of Pediatrics, The Journal of Allergy & Clinical Immunology, A Cup of Health with CDC, CDC Featured Podcasts
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Margaret M.

Contact Margaret M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants — 24 States, December 2024–April 2025

|
By Laura Zambrano, Regina M. Simeone, Margaret M. Newhams
| A Cup of Health with CDC
Weekly / November 20, 2025 / 74(37);580–588 Laura D. Zambrano, PhD1,*; Regina M. Simeone, PhD1,*; Margaret M. Newhams, MPH2; Amanda B. Payne, PhD1; Natasha B. Halasa, MD3; Amber O. Orzel-Lockwood, MPH2; Jemima M. Calixte, MS2; Satoshi Kamidani, MD, PhD4; Hillary Crandall, MD5; Melissa A. Cameron, MD6; Jennifer E. Schuster, MD7; Aline B. Maddux, MD8; Kathleen Chiotos, MD9; Katherine Irby, MD10; Steven L. Shein, MD11; Mary Allen Staat, MD12; Lora M. Martin, MSN13; Samina S. Bhumbra, MD14; Ryan A.
Open in Who Shared Issue with article?

Variation in Early Anakinra Use and Short‐Term Outcomes in Multisystem Inflammatory Syndrome in Children

|
By Joyce Chang Verified, Cameron Young, Eyal Muscal, Margaret M. Newhams
| Wiley Online Library Verified
Full Length The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the CDC. Funded by the CDC. Dr. Chang's work was supported by the NIH (grant K23-HL-148539). Drs. Muscal and Sexson Tejtel's work was supported by the NIH (grant R61-HD-105593). Abstract Objective Evidence regarding effectiveness of interleukin-1 receptor antagonism in multisystem inflammatory syndrome in children (MIS-C) is lacking.
Open in Who Shared Issue with article?

Variation in Early Anakinra Use and Short‐term Outcomes in Multisystem inflammatory Syndrome in Children

|
By Joyce Chang Verified, Cameron Young, Eyal Muscal, Margaret M. Newhams
| Wiley Online Library Verified
Full Length This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/art.42495. Abstract Objective Evidence regarding effectiveness of interleukin-1 receptor antagonism in Multisystem Inflammatory Syndrome in Children (MIS-C) is lacking.
Open in Who Shared Issue with article?
See all 13 licensed articles (16 Total)